Journal article 151 views 26 downloads
Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis
,
Roberto Angelini ,
Racheal Fosuah,
Manuela Pacciarini,
Alison Dickson,
Neil Robertson,
Laura Childs,
Samantha Loveless ,
Emma Tallantyre,
William Griffiths ,
Yuqin Wang ,
Owain Howell
Brain Pathology, Start page: e70001
Swansea University Authors:
Lauren Griffiths, Kristen Hawkins, Eylan Yutuc , Roberto Angelini , William Griffiths , Yuqin Wang , Owain Howell
-
PDF | Version of Record
© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License (CC BY).
Download (1.91MB)
DOI (Published version): 10.1111/bpa.70001
Abstract
Disability worsening in multiple sclerosis (MS) is linked to neurodegeneration. Cholesterol homeostasis is essential for normal brain function. CYP46A1, crucial for brain cholesterol turnover and reduced in some neurodegenerative diseases, is a potential neuroprotective target. We hypothesized that...
| Published in: | Brain Pathology |
|---|---|
| ISSN: | 1015-6305 1750-3639 |
| Published: |
Wiley
2025
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa68901 |
| Abstract: |
Disability worsening in multiple sclerosis (MS) is linked to neurodegeneration. Cholesterol homeostasis is essential for normal brain function. CYP46A1, crucial for brain cholesterol turnover and reduced in some neurodegenerative diseases, is a potential neuroprotective target. We hypothesized that CYP46A1 is downregulated in MS brains and linked to cholesterol dysbalance. Mass spectrometric analysis of sterols was performed from matched plasma and cerebrospinal fluid (CSF) in an all-female MS cohort (n = 32, mean age = 33). Disability status was recorded at baseline and follow-up. MS brain tissue samples (n = 11; 7 females; ages 38–67; 10 Secondary Progressive MS, 1 Primary Progressive MS; Disease Duration: 13–49 years) and control samples (n = 8; 3 females; ages 41–68) analysed for pathological regions using mass spectrometry and RNA expression using in-situ hybridization. Significant dysregulation in 25-hydroxycholesterol, 27-hydroxycholesterol and 3β-hydroxycholestenoic acid in CSF correlated with disability at baseline and follow-up in the patient population. In brain tissue, reduced cholesterol, 24S-hydroxycholesterol and 24S,25-epoxycholesterol were observed in white matter lesions (p < 0.05), linked to CYP46A1 activity. CYP46A1 expression was enriched in neurons, with reductions in MS grey matter lesions and non-lesions compared to controls (p < 0.01). Cholesterol metabolism is dysregulated in MS and is associated with reduced neuron-specific CYP46A1 expression. Modulating CYP46A1, a druggable target, may benefit progressive MS. |
|---|---|
| Keywords: |
cholesterol, cholesterol-24-hydroxylase (CYP46A1), mass spectrometry, multiple sclerosis (MS), neurodegeneration, progression, sterols |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
This work was supported by the UK MS Society [grant 94], the Research Wales Innovation Fund, the BRAIN Unit Infrastructure Award (Grant no. UA05; funded by Welsh Government through Health and Care Research Wales), MRC Impact Acceleration Account, BBSRC grant no. BB/N015932/1, BB/S019588/1, BB/L001942/1, BB/T018542/1, and by the European Union, as part of the Welsh Government-funded Academic Expertise for Business project. |
| Start Page: |
e70001 |